The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.
J Urol. 2012 Jul;188(1):130-7. doi: 10.1016/j.juro.2012.02.2569. Epub 2012 May 15.
We compared the clinical outcomes of patients with ureteral or renal stones treated with ureteroscopy, shock wave lithotripsy using HM3 (Dornier®) and nonHM3 lithotripters, and percutaneous nephrolithotomy.
A systematic literature search identified 6, 4 and 3 randomized, controlled trials of treatment of distal and proximal ureteral stones, and renal stones, respectively, published between 1995 and 2010. Overall stone-free, re-treatment and complication rates were calculated by meta-analytical techniques.
Based on the randomized, controlled trials evaluated the treatment of distal ureteral stones with semirigid ureteroscopy showed a 55% greater probability (pooled RR 1.55, 95% CI 1.13-2.56) of stone-free status at the initial assessment than treatment with shock wave lithotripsy. Patients treated with semirigid ureteroscopy were also less likely to require re-treatment than those treated with shock wave lithotripsy (nonHM3) (RR 0.14, 95% CI 0.08-0.23). The risk of complications was no different between the 2 modalities. Only 2 of the 4 randomized, controlled trials identified for proximal ureteral stones evaluated flexible ureteroscopy and each focused specifically on the treatment of stones 1.5 cm or greater, limiting their clinical relevance. The degree of heterogeneity among the studies evaluating renal stones was so great that it precluded any meaningful comparison.
Semirigid ureteroscopy is more efficacious than shock wave lithotripsy for distal ureteral stones. To our knowledge there are no relevant randomized, controlled trials of flexible ureteroscopy treatment of proximal ureteral calculi of a size commonly noted in the clinical setting. Collectively the comparative effectiveness of ureteroscopy and shock wave lithotripsy for proximal ureteral and renal calculi is poorly characterized with no meaningful published studies.
我们比较了经输尿管镜、使用 HM3(多尼尔®)和非 HM3 碎石机的体外冲击波碎石术以及经皮肾镜取石术治疗输尿管或肾结石患者的临床结果。
系统文献检索确定了 6 项、4 项和 3 项分别针对输尿管上段和下段结石、肾结石的随机对照试验,这些研究发表于 1995 年至 2010 年之间。通过荟萃分析技术计算总的结石清除率、再次治疗率和并发症发生率。
根据评估输尿管下段结石治疗的随机对照试验,半刚性输尿管镜治疗的初始评估结石清除率更高(合并 RR 1.55,95%CI 1.13-2.56),而体外冲击波碎石术的结石清除率较低。与体外冲击波碎石术(非 HM3)相比,接受半刚性输尿管镜治疗的患者再次治疗的可能性更小(RR 0.14,95%CI 0.08-0.23)。两种方法的并发症风险无差异。仅 4 项针对输尿管上段结石的随机对照试验中有 2 项评估了软性输尿管镜,且每一项都专门针对 1.5 厘米或更大的结石进行治疗,这限制了它们的临床相关性。评估肾结石的研究之间的异质性程度非常大,以至于无法进行任何有意义的比较。
半刚性输尿管镜治疗输尿管下段结石比体外冲击波碎石术更有效。据我们所知,目前尚无软性输尿管镜治疗临床上常见大小的输尿管上段结石的相关随机对照试验。总的来说,输尿管镜和体外冲击波碎石术治疗输尿管上段和肾结石的疗效特征描述很差,没有有意义的已发表研究。